天益医疗
(301097)
| 流通市值：17.12亿 | | | 总市值：34.88亿 |
| 流通股本：2894.14万 | | | 总股本：5894.74万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 163,867,248.73 | 575,755,706.89 | 387,051,372.64 | 227,316,427.9 |
| 营业收入 | 163,867,248.73 | 575,755,706.89 | 387,051,372.64 | 227,316,427.9 |
| 二、营业总成本 | 152,555,298.22 | 545,671,644.66 | 358,533,795.24 | 219,893,806.54 |
| 营业成本 | 85,333,685.23 | 328,328,844.48 | 238,446,174.78 | 146,658,398.92 |
| 税金及附加 | 2,003,451.65 | 8,007,653.77 | 6,378,665.05 | 3,442,900.38 |
| 销售费用 | 7,211,127.07 | 32,531,467.42 | 20,372,489.06 | 12,436,751.48 |
| 管理费用 | 36,137,773.08 | 107,822,182.62 | 57,285,108.03 | 36,126,152.96 |
| 研发费用 | 12,044,709.54 | 56,925,854.91 | 35,283,648.66 | 23,706,008.83 |
| 财务费用 | 9,824,551.65 | 12,055,641.46 | 767,709.66 | -2,476,406.03 |
| 其中:利息费用 | 4,505,159.06 | 13,387,835.53 | 9,771,481.17 | 5,927,102.06 |
| 其中:利息收入 | 2,491,545.18 | 15,047,073.28 | 11,909,636.34 | 8,314,464.81 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,221,541.57 | 2,836,638.32 | 1,956,223.23 | 1,557,015.08 |
| 加:投资收益 | -8,204,747.55 | -25,133,196.19 | -7,251,467.37 | -24,840.2 |
| 资产处置收益 | -3,375.63 | 2,531.17 | 272,189.5 | 272,048.53 |
| 资产减值损失(新) | -18,726.75 | -8,977,087.25 | -1,386,613.5 | -1,366,545.03 |
| 信用减值损失(新) | 2,687,468.45 | -5,895,456.59 | -4,400,814.99 | -2,018,732.11 |
| 其他收益 | 6,646,838.42 | 6,159,547.75 | 5,320,605.25 | 4,332,754.24 |
| 四、营业利润 | 11,197,865.88 | -922,960.56 | 23,027,699.52 | 10,174,321.87 |
| 加:营业外收入 | 0.68 | 14,388.87 | 14,388.86 | 14,388.66 |
| 减:营业外支出 | 13,830.09 | 9,871,247.94 | 548,020.04 | 539,409.15 |
| 五、利润总额 | 11,184,036.47 | -10,779,819.63 | 22,494,068.34 | 9,649,301.38 |
| 减:所得税费用 | 1,889,283.92 | 5,440,602.93 | 1,590,633.66 | -643,223.08 |
| 六、净利润 | 9,294,752.55 | -16,220,422.56 | 20,903,434.68 | 10,292,524.46 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 9,294,752.55 | -16,222,422.16 | 20,903,434.68 | 10,292,524.46 |
| 终止经营净利润 | - | 1,999.6 | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 9,294,752.55 | -16,220,422.56 | 20,094,143.6 | 9,483,233.38 |
| 少数股东损益 | - | 0 | 809,291.08 | 809,291.08 |
| 扣除非经常损益后的净利润 | 8,703,168.43 | -17,352,884.32 | 8,405,948.88 | 1,039,300.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.16 | -0.28 | 0.34 | 0.16 |
| (二)稀释每股收益 | 0.16 | -0.28 | 0.34 | 0.16 |
| 八、其他综合收益 | -1,015,981.82 | 4,411,878.64 | 3,445,158.59 | 1,811,581.31 |
| 归属于母公司股东的其他综合收益 | -1,015,981.82 | 4,411,878.64 | 3,445,158.59 | 1,811,581.31 |
| 九、综合收益总额 | 8,278,770.73 | -11,808,543.92 | 24,348,593.27 | 12,104,105.77 |
| 归属于母公司股东的综合收益总额 | 8,278,770.73 | -11,808,543.92 | 23,539,302.19 | 11,294,814.69 |
| 归属于少数股东的综合收益总额 | - | - | 809,291.08 | 809,291.08 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-27 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |